Kim Yuhree, Margonis Georgios A, Prescott Jason D, Tran Thuy B, Postlewait Lauren M, Maithel Shishir K, Wang Tracy S, Glenn Jason A, Hatzaras Ioannis, Shenoy Rivfka, Phay John E, Keplinger Kara, Fields Ryan C, Jin Linda X, Weber Sharon M, Salem Ahmed, Sicklick Jason K, Gad Shady, Yopp Adam C, Mansour John C, Duh Quan-Yang, Seiser Natalie, Solorzano Carmen C, Kiernan Colleen M, Votanopoulos Konstantinos I, Levine Edward A, Poultsides George A, Pawlik Timothy M
Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD.
Department of Surgery, Stanford University School of Medicine, Stanford, CA.
Ann Surg. 2017 Jan;265(1):197-204. doi: 10.1097/SLA.0000000000001527.
To evaluate conditional disease-free survival (CDFS) for patients who underwent curative intent surgery for adrenocortical carcinoma (ACC).
ACC is a rare but aggressive tumor. Survival estimates are usually reported as survival from the time of surgery. CDFS estimates may be more clinically relevant by accounting for the changing likelihood of disease-free survival (DFS) according to time elapsed after surgery.
CDFS was assessed using a multi-institutional cohort of patients. Cox proportional hazards models were used to evaluate factors associated with DFS. Three-year CDFS (CDFS3) estimates at "x" year after surgery were calculated as follows: CDFS3 = DFS(x+3)/DFS(x).
One hundred ninety-two patients were included in the study cohort; median patient age was 52 years. On presentation, 36% of patients had a functional tumor and median size was 11.5 cm. Most patients underwent R0 resection (75%) and 9% had N1 disease. Overall 1-, 3-, and 5-year DFS was 59%, 34%, and 22%, respectively. Using CDFS estimates, the probability of remaining disease free for an additional 3 years given that the patient had survived without disease at 1, 3, and 5 years, was 43%, 53%, and 70%, respectively. Patients with less favorable prognosis at baseline demonstrated the greatest increase in CDFS3 over time (eg, capsular invasion: 28%-88%, Δ60% vs no capsular invasion: 51%-87%, Δ36%).
DFS estimates for patients with ACC improved dramatically over time, in particular among patients with initial worse prognoses. CDFS estimates may provide more clinically relevant information about the changing likelihood of DFS over time.
评估接受肾上腺皮质癌(ACC)根治性手术患者的无病生存条件(CDFS)。
ACC是一种罕见但侵袭性强的肿瘤。生存估计通常报告为自手术时起的生存情况。通过考虑术后经过时间无病生存(DFS)可能性的变化,CDFS估计可能在临床上更具相关性。
使用多机构患者队列评估CDFS。采用Cox比例风险模型评估与DFS相关的因素。术后“x”年的三年CDFS(CDFS3)估计值计算如下:CDFS3 = DFS(x + 3)/DFS(x)。
研究队列纳入192例患者;患者中位年龄为52岁。就诊时,36%的患者有功能性肿瘤,中位大小为11.5厘米。大多数患者接受了R0切除(75%),9%有N1期疾病。总体1年、3年和5年DFS分别为59%、34%和22%。使用CDFS估计值,患者在1年、3年和5年无病生存后再无病生存3年的概率分别为43%、53%和70%。基线预后较差的患者随着时间推移CDFS3增加最大(例如,包膜侵犯:28% - 88%,差值60%,无包膜侵犯:51% - 87%,差值36%)。
ACC患者的DFS估计随时间显著改善,尤其是初始预后较差的患者。CDFS估计可能提供关于DFS随时间变化可能性的更具临床相关性的信息。